Post-approval studies (Phase 4)Study completedNCT01642238What this trial is testingAntithrombotic Effects of Ticagrelor Versus ClopidogrelWho this might be right forAcute Coronary Syndrome Juan J Badimon 15
Large-scale testing (Phase 3)Study completedNCT03357874What this trial is testingTicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.Who this might be right forAcute Coronary Syndrome Assistance Publique Hopitaux De Marseille 259
Not applicableUnknownNCT05911659What this trial is testingIndividualized and Combined Effects of Diabetes and Smoking on the Antiplatelet Activity of Ticagrelor in Acute Myocardial Infarction Patients Undergoing Primary PCIWho this might be right forIndividualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention Mina Wageh Mohareb 60
Large-scale testing (Phase 3)Study completedNCT02506140What this trial is testingPlatelet Reactivity in Acute Non-disabling Cerebrovascular EventsWho this might be right forStrokeIschemic Attack, Transient Beijing Tiantan Hospital 675
Post-approval studies (Phase 4)Study completedNCT02341729What this trial is testingEffects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary SyndromeWho this might be right forAcute Coronary Syndrome University Hospital, Ghent 40
Post-approval studies (Phase 4)UnknownNCT02422888What this trial is testingReducing Micro Vascular Dysfunction in Acute Myocardial Infarction by TicagrelorWho this might be right forMyocardial Infarction Amsterdam UMC, location VUmc 110
Large-scale testing (Phase 3)Study completedNCT04078737What this trial is testingClopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events IIWho this might be right forStrokeTransient Ischemic Attack Beijing Tiantan Hospital 6,412
Testing effectiveness (Phase 2)Study completedNCT03928353What this trial is testingStudy to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly SubjectsWho this might be right forHealthy SFJ Pharmaceuticals, Inc. 23
Not applicableUnknownNCT03161002What this trial is testingImpact of Biomarkers on Pharmacokinetics and Pharmacodynamics of TicagrelorWho this might be right forTicagrelorPharmacokineticsPharmacodynamics+2 more Cui Yimin 400
Post-approval studies (Phase 4)Study completedNCT03718429What this trial is testingPharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet TherapiesWho this might be right forCoronary Artery DiseasePeripheral Arterial DiseaseAtrial Fibrillation University of Florida 86
Large-scale testing (Phase 3)Study completedNCT01225562What this trial is testingPrevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of AspirinWho this might be right forMyocardial InfarctionCardiovascular DeathAtherothrombosis+1 more AstraZeneca 21,379
Not applicableStudy completedNCT03197298What this trial is testingChange of Dual Antiplatelet Therapy in Patients With Acute Coronary SyndromeWho this might be right forAcute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents Thorax Centrum Twente 2,062
Not applicableLooking for participantsNCT05566301What this trial is testingMulticentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)Who this might be right forClopidogrel, Poor Metabolism ofCarotid Stenosis IRCCS Policlinico S. Donato 1,140
Testing effectiveness (Phase 2)Study completedNCT02120092What this trial is testingThe Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in ManWho this might be right forAcute Coronary Syndrome Medical University of Vienna 89
Post-approval studies (Phase 4)Study completedNCT01812200What this trial is testingAntithrombotic Triple Therapy in HumansWho this might be right forAtrial FibrillationAcute Coronary Syndrome Medical University of Vienna 60
Large-scale testing (Phase 3)Looking for participantsNCT05997693What this trial is testingOne-Month DAPT in CABG PatientsWho this might be right forChronic Coronary Disease Weill Medical College of Cornell University 700
Large-scale testing (Phase 3)Looking for participantsNCT06653348What this trial is testingTicagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic StrokeWho this might be right forIschemic StrokeTransient Ischemic Attack Mazandaran University of Medical Sciences 100
Early research (Phase 1)Active Not RecruitingNCT06671470What this trial is testingA Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy SubjectsWho this might be right forInsomnia Shanghai Haiyan Pharmaceutical Technology Co., Ltd. 27
Post-approval studies (Phase 4)Study completedNCT02639143What this trial is testingRapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI PatientsWho this might be right forInflammationThrombosis First Affiliated Hospital of Harbin Medical University 50
Post-approval studies (Phase 4)UnknownNCT03620760What this trial is testingEfficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent ImplantationWho this might be right forUnstable Angina PectorisCoronary Stent Implantation Xiaofan Wu 2,036